The gap between Allianz’s headline operating performance and what actually reaches the bottom line has rarely been wider — and it is that very disconnect that is now driving the debate over the insurer’s shares.
At 440.90 euros, the stock sits just 0.7 percent below its 52-week high of 443.80 euros, having clawed back most of the ground lost in the immediate aftermath of the group’s second-quarter results on August 7. The recovery has been fuelled largely by a wave of analyst commentary, though the messages coming out of the sell-side are anything but uniform.
A Record Quarter With a Sting in the Tail
The numbers themselves tell a story of operational excellence shadowed by strategic expense. Allianz posted an operating profit of 4.874 billion euros for the second quarter — the highest quarterly figure in the company’s history — driven by its life and health insurance operations and the asset management division, while property and casualty underwriting lagged.
Yet the net result told a different tale. Reuters reported that net profit fell 8.7 percent to 2.600 billion euros, weighed down by restructuring charges tied to IT assets. The company attributed the costs to its accelerated push into artificial intelligence, a transformation it insists will ultimately drive earnings growth.
For all the mixed signals, management reaffirmed its full-year 2026 targets, insisting the group remains on track despite the one-off drag.
The Analyst Divide: 325 to 684 Euros
The market’s interpretation of those IT costs has produced one of the widest target-price spreads seen on a major European insurer in some time. Berenberg, which published its initial note within hours of the results and reiterated its stance on August 10, stands firmly in the bull camp with a buy rating and a 684-euro price target, citing anticipated profit growth from AI efficiencies and continued inflows into asset management.
At the opposite end of the spectrum sits Jefferies, which kept its “Hold” rating and a price target of just 325 euros — a level far below where the shares currently trade. The chasm between those two figures underscores just how differently the market is weighing the sustainability of the record operating result against the near-term earnings drag of the technological overhaul.
Should investors sell immediately? Or is it worth buying Allianz?
RBC occupies something of a middle ground. The bank lifted its target to 450 euros on August 10 while maintaining a neutral “Sector Perform” stance, pointing to the strong quarter and recent acquisitions as justification for the upward revision.
An Asian Expansion Takes Shape
Those acquisitions are worth a closer look. Allianz Global Investors, the group’s fund management arm, agreed in early August to acquire UOB Asset Management from Singapore’s United Overseas Bank. Media reports put the price tag at roughly 430 million US dollars or 555 million Singapore dollars, depending on the source and currency conversion.
The deal fits neatly into Allianz’s growth strategy for its asset management business, which was already a key contributor to the record quarterly result. RBC specifically cited such bolt-on purchases as a reason for its raised target.
Buybacks Keep the Floor Firm
Meanwhile, the company’s share repurchase programme continues to run in the background. Between July 27 and 31, Allianz bought back 234,428 of its own shares at average prices ranging from 428.43 to 432.58 euros. Since the programme began in March, cumulative buybacks have reached roughly 4.7 million shares — a steady tailwind that analysts say helps explain the stock’s proximity to its record high.
The technical picture reinforces that resilience. The shares have gained 13 percent since the start of the year (12 percent according to one count) and 19 percent over twelve months. On a 30-day view, the stock is up 4.5 percent, with an RSI of 66.5 suggesting demand is ambitious but not yet overbought.
What emerges is a company executing on multiple fronts — record operations, an aggressive expansion in Asia, and a steady return of capital — while absorbing the costs of a technological transition that is clearly not yet complete. Whether the shares deserve to trade near their highs or well below them is a question the analysts cannot agree on. The market, for now, seems to be siding with the optimists.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from August 13 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 13.
Allianz: Buy or sell? Read more here...
